90 related articles for article (PubMed ID: 15989461)
1. Immunological predictors of survival in HIV type 2-infected rural villagers in Guinea-Bissau.
Jaffar S; Van der Loeff MS; Eugen-Olsen J; Vincent T; Sarje-Njie R; Ngom P; Meyer AM; Berry N; Aaby P; Whittle H
AIDS Res Hum Retroviruses; 2005 Jun; 21(6):560-4. PubMed ID: 15989461
[TBL] [Abstract][Full Text] [Related]
2. Low level viremia and high CD4% predict normal survival in a cohort of HIV type-2-infected villagers.
Berry N; Jaffar S; Schim van der Loeff M; Ariyoshi K; Harding E; N'Gom PT; Dias F; Wilkins A; Ricard D; Aaby P; Tedder R; Whittle H
AIDS Res Hum Retroviruses; 2002 Nov; 18(16):1167-73. PubMed ID: 12487822
[TBL] [Abstract][Full Text] [Related]
3. Are plasma biomarkers of immune activation predictive of HIV progression: a longitudinal comparison and analyses in HIV-1 and HIV-2 infections?
Nyamweya S; Townend J; Zaman A; Steele SJ; Jeffries D; Rowland-Jones S; Whittle H; Flanagan KL; Jaye A
PLoS One; 2012; 7(9):e44411. PubMed ID: 22970212
[TBL] [Abstract][Full Text] [Related]
4. The effects of HIV-2 infection in a rural area of Guinea-Bissau.
Ricard D; Wilkins A; N'Gum PT; Hayes R; Morgan G; Da Silva AP; Whittle H
AIDS; 1994 Jul; 8(7):977-82. PubMed ID: 7946109
[TBL] [Abstract][Full Text] [Related]
5. High plasma levels of intact and cleaved soluble urokinase receptor reflect immune activation and are independent predictors of mortality in HIV-1-infected patients.
Ostrowski SR; Piironen T; Høyer-Hansen G; Gerstoft J; Pedersen BK; Ullum H
J Acquir Immune Defic Syndr; 2005 May; 39(1):23-31. PubMed ID: 15851910
[TBL] [Abstract][Full Text] [Related]
6. Serum HIV-1 RNA levels compared to soluble markers of immune activation to predict disease progression in HIV-1-infected individuals.
Zangerle R; Steinhuber S; Sarcletti M; Dierich MP; Wachter H; Fuchs D; Möst J
Int Arch Allergy Immunol; 1998 Jul; 116(3):228-39. PubMed ID: 9693271
[TBL] [Abstract][Full Text] [Related]
7. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
[TBL] [Abstract][Full Text] [Related]
8. HIV type 2 pathogenicity is not related to subtype in rural Guinea Bissau.
Xiang Z; Ariyoshi K; Wilkins A; Dias F; Whittle H; Breuer J
AIDS Res Hum Retroviruses; 1997 Apr; 13(6):501-5. PubMed ID: 9100992
[TBL] [Abstract][Full Text] [Related]
9. The predictive value of several markers in the progression to acquired immunodeficiency syndrome.
Planella T; Cortés M; Martínez-Brú C; Barrio J; Sambeat MA; González-Sastre F
Clin Chem Lab Med; 1998 Mar; 36(3):169-73. PubMed ID: 9589805
[TBL] [Abstract][Full Text] [Related]
10. The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea-Bissau.
Eugen-Olsen J; Gustafson P; Sidenius N; Fischer TK; Parner J; Aaby P; Gomes VF; Lisse I
Int J Tuberc Lung Dis; 2002 Aug; 6(8):686-92. PubMed ID: 12150480
[TBL] [Abstract][Full Text] [Related]
11. Undetectable plasma viral load predicts normal survival in HIV-2-infected people in a West African village.
van der Loeff MF; Larke N; Kaye S; Berry N; Ariyoshi K; Alabi A; van Tienen C; Leligdowicz A; Sarge-Njie R; da Silva Z; Jaye A; Ricard D; Vincent T; Jones SR; Aaby P; Jaffar S; Whittle H
Retrovirology; 2010 May; 7():46. PubMed ID: 20482865
[TBL] [Abstract][Full Text] [Related]
12. Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection.
Mildvan D; Spritzler J; Grossberg SE; Fahey JL; Johnston DM; Schock BR; Kagan J
Clin Infect Dis; 2005 Mar; 40(6):853-8. PubMed ID: 15736019
[TBL] [Abstract][Full Text] [Related]
13. 9-year HIV-2-associated mortality in an urban community in Bissau, west Africa.
Poulsen AG; Aaby P; Larsen O; Jensen H; Nauclér A; Lisse IM; Christiansen CB; Dias F; Melbye M
Lancet; 1997 Mar; 349(9056):911-4. PubMed ID: 9093252
[TBL] [Abstract][Full Text] [Related]
14. Immune stimulation by syphilis and malaria in HIV-2-infected and uninfected villagers in West Africa.
N'Gom PT; Jaffar S; Ricard D; Wilkins A; Ariyoshi K; Morgan G; Da Silva AP; Whittle HC
Br J Biomed Sci; 1997 Dec; 54(4):251-5. PubMed ID: 9624734
[TBL] [Abstract][Full Text] [Related]
15. CD4 intragenic SNPs associate with HIV-2 plasma viral load and CD4 count in a community-based study from Guinea-Bissau, West Africa.
Hennig BJ; Velez-Edwards DR; Schim van der Loeff MF; Bisseye C; Edwards TL; Tacconelli A; Novelli G; Aaby P; Kaye S; Scott WK; Jaye A; Whittle HC; Williams SM; Hill AV; Sirugo G
J Acquir Immune Defic Syndr; 2011 Jan; 56(1):1-8. PubMed ID: 20924289
[TBL] [Abstract][Full Text] [Related]
16. High mortality risk among individuals assumed to be TB-negative can be predicted using a simple test.
Rabna P; Andersen A; Wejse C; Oliveira I; Gomes VF; Haaland MB; Aaby P; Eugen-Olsen J
Trop Med Int Health; 2009 Sep; 14(9):986-94. PubMed ID: 19725925
[TBL] [Abstract][Full Text] [Related]
17. Estimation of virological and immunological parameters in subjects from South India infected with human immunodeficiency virus type 1 clade C and correlation of findings with occurrence of neurological disease.
Kamat A; Ravi V; Desai A; Satishchandra P; Satish KS; Kumar M
J Neurovirol; 2009 Jan; 15(1):25-35. PubMed ID: 19031329
[TBL] [Abstract][Full Text] [Related]
18. Mortality among human immunodeficiency virus type 2-positive villagers in rural Guinea-Bissau is correlated with viral genotype.
Grassly NC; Xiang Z; Ariyoshi K; Aaby P; Jensen H; Schim van der Loeff M; Dias F; Whittle H; Breuer J
J Virol; 1998 Oct; 72(10):7895-9. PubMed ID: 9733826
[TBL] [Abstract][Full Text] [Related]
19. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid and plasma HIV-1 RNA levels and lopinavir concentrations following lopinavir/ritonavir regimen.
Yilmaz A; Ståhle L; Hagberg L; Svennerholm B; Fuchs D; Gisslén M
Scand J Infect Dis; 2004; 36(11-12):823-8. PubMed ID: 15764168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
